Literature DB >> 20499172

Atypical hemolytic uremic syndrome in the Tunisian population.

Nadia Leban1, Sabra Aloui, Dalel Touati, Ramzy Lakhdhar, Habib Skhiri, Gerard Lefranc, Abdellatif Achour, Mezri Elmay, Margarita Lopez-Trascasa, Pilar Sanchez-Corral, Jemni Chibani, Amel Haj Khelil.   

Abstract

BACKGROUND: Hemolytic uremic syndrome consists of a triad of acquired hemolytic anemia, thrombocytopenia and renal failure. AIM: Our objectives were to determine epidemiology, clinical and laboratory characteristics of patients with atypical hemolytic uremic syndrome (aHUS) to determine the relationship between the complement protein deficit and aHUS in the Tunisian population.
METHODS: We studied retrospectively four cases of atypical HUS in adults admitted in the Nephrology Department of Fattouma Bourguiba Universitary Hospital in Monastir between 2000 and 2008.
RESULTS: Three patients had renal failure that required dialysis. One of them received kidney transplantation with no further recurrence of aHUS. Three patients had normal C3, C4, CFH, and FB levels, and in all patients anti-FH autoantibodies were absent. The kidney biopsy of one patient showed in addition to lupus glomerulonephritis histological findings consistent with TMA. A decrease in C3, C4 and CFH levels in this patient was found both before and after the cure.
CONCLUSION: Nephrologists should be aware of autoimmune conditions and genetic abnormalities of the complement regulatory genes as possible pathogenic mechanisms in atypical HUS patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499172     DOI: 10.1007/s11255-010-9754-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor.

Authors:  Rosemary L Donne; Ian Abbs; Peter Barany; Carl-Gustaf Elinder; Mark Little; Peter Conlon; Timothy H J Goodship
Journal:  Am J Kidney Dis       Date:  2002-12       Impact factor: 8.860

Review 2.  Thrombotic microangiopathies.

Authors:  Joel L Moake
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

Review 3.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 4.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

Review 5.  Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.

Authors:  Anna Richards; M Kathryn Liszewski; David Kavanagh; Celia J Fang; Elizabeth Moulton; Veronique Fremeaux-Bacchi; Giuseppe Remuzzi; Marina Noris; Timothy H J Goodship; John P Atkinson
Journal:  Mol Immunol       Date:  2006-08-01       Impact factor: 4.407

6.  Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Elizabeth J Kemp; Elizabeth Mayland; Robin J Winney; Jeremy S Duffield; Graham Warwick; Anna Richards; Roy Ward; Judith A Goodship; Timothy H J Goodship
Journal:  J Am Soc Nephrol       Date:  2005-05-25       Impact factor: 10.121

7.  Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3,B7 haplotype.

Authors:  L Carreras; R Romero; C Requesens; A J Oliver; M Carrera; M Clavo; J Alsina
Journal:  JAMA       Date:  1981-02-13       Impact factor: 56.272

8.  Human complement factor H deficiency associated with hemolytic uremic syndrome.

Authors:  N Rougier; M D Kazatchkine; J P Rougier; V Fremeaux-Bacchi; J Blouin; G Deschenes; B Soto; V Baudouin; B Pautard; W Proesmans; E Weiss; L Weiss
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

9.  Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Authors:  Anne-Laure Sellier-Leclerc; Veronique Fremeaux-Bacchi; Marie-Agnès Dragon-Durey; Marie-Alice Macher; Patrick Niaudet; Geneviève Guest; Bernard Boudailliez; François Bouissou; Georges Deschenes; Sophie Gie; Michel Tsimaratos; Michel Fischbach; Denis Morin; Hubert Nivet; Corinne Alberti; Chantal Loirat
Journal:  J Am Soc Nephrol       Date:  2007-06-28       Impact factor: 10.121

Review 10.  Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.

Authors:  Elena Bresin; Erica Daina; Marina Noris; Federica Castelletti; Rumen Stefanov; Prudence Hill; Timothy H J Goodship; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 8.237

View more
  3 in total

1.  Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.

Authors:  Gia Oh; Keith K Lau
Journal:  Int Urol Nephrol       Date:  2011-11-25       Impact factor: 2.370

Review 2.  Systematic review of atypical hemolytic uremic syndrome biomarkers.

Authors:  Rupesh Raina; Sidharth K Sethi; Marie-Agnès Dragon-Durey; Amrit Khooblall; Divya Sharma; Priyanka Khandelwal; Ron Shapiro; Olivia Boyer; Hui Kim Yap; Arvind Bagga; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2022-02-03       Impact factor: 3.651

3.  Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.

Authors:  Megha Gupta; Shravya Govindappagari; Richard M Burwick
Journal:  Obstet Gynecol       Date:  2020-01       Impact factor: 7.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.